Bioplastics show promise in search for antibacterial packagingBioplastics made from protein sources such as albumin and whey have shown significant antibacterial properties, findings that could...
When tested on the skin of mice, a new experimental therapy that uses nanoparticles to deliver an enzyme blocker cut wound healing time in half compared with no treatment.
At least 30 dogs in England have been killed in less than 18 months by an unknown disease which causes skin lesions and kidney failure, reveals research published in Veterinary Record.
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, has announced study results demonstrating that its DecisionDx-Melanoma™ gene expression profile...
Celgene Corporation has announced that results from its ongoing phase III LIBERATE trial evaluating Otezla® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4)...
Sebacia, Inc., a company dedicated to delivering breakthrough treatments to advance dermatology, has announced new research showing that selective targeting of sebaceous glands using the Sebacia...